Chronus Pharmaceuticals receives second STTR Phase 1 Award

Stony Brook, NY: Chronus Pharmaceuticals has received a $224,999 Phase I Small Business Technology Transfer (STTR) award in partnership with the Department of Chemistry at Stony Brook University. Funding from the National Institute of Biomedical Imaging and bioengineering of the National Institutes of Health (NIH) will be used to establish feasibility of an PET diagnostic for prosthetic joint infections. The research will be lead by Peter J Tonge, PhD in the Department of Chemistry, who will serve as principle investigator on the award and work in close collaboration with Chronus Pharmaceuticals.